- ÍtemEmbargoGlaucoma pseudoexfoliativo. Reporte de un caso(Universidad Católica de Cuenca., 2023) Quezada Nivelo, María Paula; Cervantes Anaya, Luis Alberto; 0105846109Pseudoexfoliative glaucoma (GP) is a chronic progressive optic neuropathy by the presence of grayish fibrillar material in the anterior segment of the eye. The clinical picture varies and may include elevated intraocular pressure (IOP) due to aqueous humor blockage, cataract, visual field loss, optic nerve damage and phacodonesis. The GP can have genetic, environmental, or dietary origins. Case report: Male patient, 69 years old, has a history of hypertension and hypercholesterolemia, and has undergone cataract surgery in both eyes. GP was made based on the patient’s physical examination, which revealed the presence of pseudoexfoliative material in intraocular lenses and the pupillary border. The Intraocular Pressure (IOP) in the right eye was measured at 25 mmHg and 26 mmHg in the left eye. Complementary examinations, such as visual field study, optic nerve photography, and optical coherence tomography (OCT), confirmed the diagnosis. Finally, the treatment involved pharmacological and surgical interventions. A Selective Laser Trabeculoplasty (SLT) was performed in both eyes, using1M mJ energy, to facilitate the drainage of the aqueous humor, and, therefore, reduce the IOP. After three months of SLT and therapy with a triple hypotensive combination, the patient’s tonometry results were as follows: Right Eye: 12 mmHg, Left Eye: 11 mmHg. These results indicate a favorable therapeutic. The patient has reported fewer symptoms and shown compliance and promising therapeutic adherence. SLT should be considered as a therapeutic alternative.
- ÍtemEmbargoImpacto del SARS-COV-2 en pacientes con enfermedad inflamatoria intestinal(Universidad Católica de Cuenca., 2023) Japa Guzmán, Pedro Alexander; Orellana Bernal, Paola Veronica; 1106014424Introduction: Inflammatory bowel disease (IBD) is a group of chronic disorders of the gastrointestinal system that includes conditions such as Crohn's disease and ulcerative colitis. Patients often require immunosuppressive and biological treatments to control the illness. With the emergence of the COVID-19 pandemic caused by the SARS-CoV-2 virus, particular concern arose about how this infection could affect people with IBD and whether immunosuppressive treatments could increase their vulnerability. Objective: To establish, through scientific articles, the impact of COVID-19 on patients with Inflammatory bowel diseases. Methodology: Narrative literature review. Results: IBD patients do not appear to be at increased risk of contracting SARS-CoV-2 infection compared to the general population. However, those who develop COVID-19 may be at increased risk of serious complications, especially if they are undergoing immunosuppressive treatment. Risk factors associated with COVID-19 in IBD patients include older age, the presence of comorbidities, and the use of medications such as high-dose corticosteroids. Diarrhea is a common symptom in patients with IBD and COVID-19, and in some cases, it may be the only symptom at the onset of infection. Gastrointestinal symptoms can mimic an IBD relapse. Conclusions: IBD patients do not appear to have a higher risk of contracting SARS-CoV-2 infection compared to the general population, but they have an increased risk of complications associated with the drugs used.
- ÍtemAcceso AbiertoEnfermedad indiferenciada del tejido conectivo: reporte de un caso(Universidad Católica de Cuenca., 2023) Sabando Ponce, Denisse Michelle; Salamea Sarmiento, Cecibel; 1315347987Undifferentiated Connective Tissue Disease (UCTD) is an autoimmune pathology of unknown origin. Its clinical presentation is diverse, as it presents signs and symptoms that affect the joints, tissues, and organs that could indicate a connective tissue disease. Nevertheless, it does not meet the necessary criteria to be considered as such, thus being related to autoimmune syndromes such as rheumatoid arthritis, systemic lupus erythematosus, and systemic sclerosis, among others. The clinical case of a 42-year-old patient is presented, who was admitted for suspected UCTD, which was confirmed during his hospital stay through clinical findings and complementary studies.
- ÍtemEmbargoCraneofaringioma y la importancia del reservorio Ommaya para su tratamiento(Universidad Católica de Cuenca., 2023) Castañeda Cárdenas, Jaime Ernesto; Ochoa Aucay, Jorge; 0105926109Introduction: The research focuses on the use of the Ommaya reservoir in the treatment of craniopharyngioma, a rare brain tumor that presents significant clinical challenges due to its location near the hypothalamus and pituitary gland. The study seeks to understand the effectiveness, safety and impact on quality of life of this medical device in the management of the disease. Overall objective: The main objective was to evaluate the efficacy of the Ommaya reservoir as part of the treatment of craniopharyngioma, considering both clinical data and patient experiences. It seeks to provide a comprehensive view of its usefulness and its impact on patients' quality of life. Methodology: The project will use a narrative literature review research design, conducting a comprehensive review of the medical literature to establish background and trends. In addition, clinical cases of craniopharyngioma and the importance of the Ommaya reservoir for its treatment will be analyzed. Expected results: A complete understanding of the effectiveness of the Ommaya reservoir in the treatment of craniopharyngioma is expected to be obtained, identifying response patterns and complications. However, it allows us to obtain valuable information about how this device impacts the quality of life of patients from their perspective. The results of this research may contribute to improving the management of this rare and complex brain disease, providing valuable information for both clinicians and patients.
- ÍtemEmbargoBeneficios de la implementación de prebióticos en la leche de fórmula(Universidad Católica de Cuenca., 2023) Ocampo Serrano, Jeniffer Salomé; Merchán Bustos, Fabián Andrés; 0105353312; Fabián AndrésIntroduction: Over the years, infant food industries have sought to improve their products, emphasizing the health and good nutrition of consumers to achieve a result almost similar to breast milk. At the end of the 20th century, the use of prebiotics in infant formula was introduced, which proved to be very beneficial for the infant's body by reinforcing the consumer's intestinal microbiota and enhancing their immune system, thus achieving a great impact and an effect similar to that obtained from human milk. General objective: To identify the benefits of prebiotics that have been added to certain infant formulas in our environment. Methodology: An exhaustive literature review has been conducted to analyze and collect data based on the benefits of prebiotics implemented in infant formula, using specific inclusion criteria. Articles not relevant to the topic have been excluded, and the search has been carried out through databases such as Scopus, PubMed, and Web of Science, employing search terms and Boolean operators such as (AND, OR, NOT). Expected results: Identification and analysis of the benefits of prebiotics currently implemented in infant formula.